TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07142707: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity

Sponsor: MBX Biosciences · Phase: PHASE1 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 124 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$7,224,320

Rescue Site Savings

+$4,763,536

Unlock Full NCT07142707 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07142707 Rescue Dossier →